エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/04/02 | 3,295 | 3,305 | 3,240 | 3,240 | -50 | -1.5% | 1,440,700 |
| 2012/03/30 | 3,275 | 3,290 | 3,270 | 3,290 | +20 | +0.6% | 1,581,800 |
| 2012/03/29 | 3,245 | 3,270 | 3,240 | 3,270 | +5 | +0.2% | 1,073,100 |
| 2012/03/28 | 3,285 | 3,295 | 3,250 | 3,265 | -120 | -3.5% | 1,992,900 |
| 2012/03/27 | 3,370 | 3,385 | 3,360 | 3,385 | +25 | +0.7% | 1,699,600 |
| 2012/03/26 | 3,360 | 3,370 | 3,355 | 3,360 | -5 | -0.1% | 958,600 |
| 2012/03/23 | 3,350 | 3,370 | 3,350 | 3,365 | ±0 | ±0% | 1,073,200 |
| 2012/03/22 | 3,355 | 3,370 | 3,350 | 3,365 | +15 | +0.4% | 1,263,300 |
| 2012/03/21 | 3,365 | 3,370 | 3,350 | 3,350 | -15 | -0.4% | 1,111,000 |
| 2012/03/19 | 3,355 | 3,370 | 3,350 | 3,365 | +10 | +0.3% | 553,000 |
| 2012/03/16 | 3,350 | 3,360 | 3,340 | 3,355 | +10 | +0.3% | 816,800 |
| 2012/03/15 | 3,330 | 3,350 | 3,325 | 3,345 | +15 | +0.5% | 1,057,300 |
| 2012/03/14 | 3,340 | 3,345 | 3,330 | 3,330 | ±0 | ±0% | 789,900 |
| 2012/03/13 | 3,335 | 3,350 | 3,330 | 3,330 | -15 | -0.4% | 1,308,600 |
| 2012/03/12 | 3,350 | 3,355 | 3,335 | 3,345 | +5 | +0.1% | 1,051,200 |
| 2012/03/09 | 3,350 | 3,350 | 3,310 | 3,340 | +15 | +0.5% | 3,858,500 |
| 2012/03/08 | 3,315 | 3,330 | 3,310 | 3,325 | +5 | +0.2% | 1,164,200 |
| 2012/03/07 | 3,310 | 3,345 | 3,310 | 3,320 | -30 | -0.9% | 1,078,600 |
| 2012/03/06 | 3,330 | 3,350 | 3,310 | 3,350 | +15 | +0.4% | 1,511,500 |
| 2012/03/05 | 3,325 | 3,350 | 3,320 | 3,335 | +15 | +0.5% | 995,200 |
| 2012/03/02 | 3,290 | 3,320 | 3,290 | 3,320 | +40 | +1.2% | 1,091,500 |
| 2012/03/01 | 3,295 | 3,310 | 3,270 | 3,280 | -10 | -0.3% | 1,345,900 |
| 2012/02/29 | 3,300 | 3,330 | 3,290 | 3,290 | -5 | -0.2% | 1,577,700 |
| 2012/02/28 | 3,270 | 3,295 | 3,265 | 3,295 | +20 | +0.6% | 942,700 |
| 2012/02/27 | 3,260 | 3,290 | 3,240 | 3,275 | +20 | +0.6% | 1,235,600 |
| 2012/02/24 | 3,260 | 3,265 | 3,240 | 3,255 | ±0 | ±0% | 1,197,400 |
| 2012/02/23 | 3,240 | 3,270 | 3,235 | 3,255 | +10 | +0.3% | 1,213,300 |
| 2012/02/22 | 3,220 | 3,265 | 3,220 | 3,245 | +40 | +1.2% | 1,692,200 |
| 2012/02/21 | 3,180 | 3,210 | 3,180 | 3,205 | +20 | +0.6% | 1,226,800 |
| 2012/02/20 | 3,185 | 3,190 | 3,170 | 3,185 | +25 | +0.8% | 873,100 |
| 2012/02/17 | 3,170 | 3,185 | 3,160 | 3,160 | +5 | +0.2% | 1,347,700 |
| 2012/02/16 | 3,160 | 3,170 | 3,150 | 3,155 | -5 | -0.2% | 898,400 |
| 2012/02/15 | 3,150 | 3,175 | 3,140 | 3,160 | +10 | +0.3% | 1,248,800 |
| 2012/02/14 | 3,180 | 3,180 | 3,150 | 3,150 | -20 | -0.6% | 930,500 |
| 2012/02/13 | 3,175 | 3,185 | 3,150 | 3,170 | +30 | +1% | 788,200 |
| 2012/02/10 | 3,120 | 3,145 | 3,115 | 3,140 | +15 | +0.5% | 986,700 |
| 2012/02/09 | 3,130 | 3,140 | 3,125 | 3,125 | ±0 | ±0% | 690,400 |
| 2012/02/08 | 3,120 | 3,130 | 3,115 | 3,125 | +5 | +0.2% | 680,400 |
| 2012/02/07 | 3,120 | 3,135 | 3,110 | 3,120 | ±0 | ±0% | 893,700 |
| 2012/02/06 | 3,130 | 3,130 | 3,105 | 3,120 | -5 | -0.2% | 964,200 |
| 2012/02/03 | 3,180 | 3,180 | 3,120 | 3,125 | -55 | -1.7% | 1,175,900 |
| 2012/02/02 | 3,175 | 3,185 | 3,155 | 3,180 | +25 | +0.8% | 1,002,000 |
| 2012/02/01 | 3,175 | 3,185 | 3,140 | 3,155 | ±0 | ±0% | 746,900 |
| 2012/01/31 | 3,170 | 3,190 | 3,150 | 3,155 | -5 | -0.2% | 946,400 |
| 2012/01/30 | 3,150 | 3,165 | 3,140 | 3,160 | +10 | +0.3% | 583,500 |
| 2012/01/27 | 3,140 | 3,165 | 3,135 | 3,150 | +30 | +1% | 1,309,400 |
| 2012/01/26 | 3,105 | 3,135 | 3,105 | 3,120 | +20 | +0.6% | 696,700 |
| 2012/01/25 | 3,135 | 3,135 | 3,085 | 3,100 | -40 | -1.3% | 1,809,100 |
| 2012/01/24 | 3,135 | 3,155 | 3,130 | 3,140 | +10 | +0.3% | 1,156,300 |
| 2012/01/23 | 3,130 | 3,135 | 3,115 | 3,130 | -20 | -0.6% | 813,600 |
3201～
3250
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
